» Articles » PMID: 20486907

Evolution of Causes and Risk Factors for Mortality Post-liver Transplant: Results of the NIDDK Long-term Follow-up Study

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2010 May 22
PMID 20486907
Citations 218
Authors
Affiliations
Soon will be listed here.
Abstract

Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns of and risk factors for long-term mortality. We analyzed the multicenter, prospectively obtained The National Institute of Diabetes and Digestive and Kidney Diseases LT Database of 798 transplant recipients from 1990 to 1994 (follow-up 2003). Overall, 327 recipients died. Causes of death >1 year: 28% hepatic, 22% malignancy, 11% cardiovascular, 9% infection, 6% renal failure. Renal-related death increased dramatically over time. Risk factors for death >1 year (univariate): male gender, age/decade, pre-LT diabetes, post-LT diabetes, post-LT hypertension, post-LT renal insufficiency, retransplantation >1 year, pre-LT malignancy, alcoholic disease (ALD) and metabolic liver disease, with similar risks noted for death >5 years. Hepatitis C, retransplantation, post-LT diabetes, hypertension and renal insufficiency were significant risk factors for liver-related death. Cardiac deaths associated with age, male gender, ALD, cryptogenic disease, pre-LT hypertension and post-LT renal insufficiency. In summary, the leading causes of late deaths after transplant were graft failure, malignancy, cardiovascular disease and renal failure. Older age, diabetes and renal insufficiency identified patients at highest risk of poor survival overall. Diligent management of modifiable post-LT factors including diabetes, hypertension and renal insufficiency may impact long-term mortality.

Citing Articles

Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation.

Safi K, Pawlicka A, Pradhan B, Sobieraj J, Zhylko A, Struga M Biomedicines. 2025; 13(2).

PMID: 40002907 PMC: 11852418. DOI: 10.3390/biomedicines13020494.


Advances, challenges and future applications of liver organoids in experimental regenerative medicine.

Gong D, Mo J, Zhai M, Zhou F, Wang G, Ma S Front Med (Lausanne). 2025; 11:1521851.

PMID: 39927267 PMC: 11804114. DOI: 10.3389/fmed.2024.1521851.


Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification.

Mak L, Fung J, Lo G, Lo C, Wu T, Chung M Front Med (Lausanne). 2025; 11:1502055.

PMID: 39895824 PMC: 11782125. DOI: 10.3389/fmed.2024.1502055.


Prostaglandin E1 administration post liver transplantation and renal outcomes: A retrospective single center experience.

Jahagirdar V, Ahmed M, Fatima I, Ali H, Alba L, Helzberg J World J Transplant. 2024; 14(4):98797.

PMID: 39697460 PMC: 11438947. DOI: 10.5500/wjt.v14.i4.98797.


Thrombotic complications post liver transplantation: Etiology and management.

Srivastava S, Garg I World J Crit Care Med. 2024; 13(4):96074.

PMID: 39655303 PMC: 11577539. DOI: 10.5492/wjccm.v13.i4.96074.


References
1.
Leonard J, Heimbach J, Malinchoc M, Watt K, Charlton M . The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008; 8(3):667-72. DOI: 10.1111/j.1600-6143.2007.02100.x. View

2.
Oufroukhi L, Kamar N, Muscari F, Lavayssiere L, Guitard J, Ribes D . Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation. 2008; 85(10):1436-42. DOI: 10.1097/TP.0b013e31816f1b7c. View

3.
Pfitzmann R, Nussler N, Hippler-Benscheidt M, Neuhaus R, Neuhaus P . Long-term results after liver transplantation. Transpl Int. 2007; 21(3):234-46. DOI: 10.1111/j.1432-2277.2007.00596.x. View

4.
Gooley T, Leisenring W, Crowley J, Storer B . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18(6):695-706. DOI: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o. View

5.
Watt K, Pedersen R, Kremers W, Heimbach J, Sanchez W, Gores G . Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology. 2009; 137(6):2010-7. PMC: 2789872. DOI: 10.1053/j.gastro.2009.08.070. View